Clin Psychopharmacol Neurosci.  2023 Aug;21(3):572-582. 10.9758/cpn.22.1047.

Oxidative Stress and Inflammatory Biomarkers in People with Methamphetamine Use Disorder

• Turan
• enormanci G
• Neşelioğlu S
• Budak Y
• Erel
• Şenormancı

• KMID: 2545816
• DOI: http://doi.org/10.9758/cpn.22.1047

Abstract

Objective
This study aimed to investigate the blood serum levels of biomarkers specifying oxidative stress status and systemic inflammation between people using methamphetamine (METH) and the control group (CG). Serum thiol/disulfide balance and ischemia-modified albumin levels were studied to determine oxidative stress, and serum interleukin-6 (IL-6) levels and complete blood count (CBC) were to assess inflammation.
Methods
Fifty patients with METH use disorder (MUD) and 36 CG participants were included in the study. Two tubes of venous blood samples were taken to measure oxidative stress, serum thiol/disulfide balance, ischemia-modified albumin, and IL-6 levels between groups. The correlation of parameters measuring oxidative stress and inflammation between groups with sociodemographic data was investigated.
Results
In this study, serum total thiol, free thiol levels, disulfide/native thiol percentage ratios, and serum ischemia-modified albumin levels of the patients were statistically significantly higher than the healthy controls. No difference was observed between the groups in serum disulfide levels and serum IL-6 levels. Considering the regression analysis, only the duration of substance use was a statistically significant factor in explaining serum IL-6 levels. The parameters showing inflammation in the CBC were significantly higher in the patients than in the CG.
Conclusion
CBC can be used to evaluate systemic inflammation in patients with MUD. Parameters measuring thiol/disulfide homeostasis and ischemia-modified albumin can be, also, used to assess oxidative stress.

Keyword

Methamphetamine; Addiction; Interleukin-6; Disulfides; Thiols; Serum albumin